Expression of concern: Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey
© Harris; licensee BioMed Central. 2016
Received: 13 January 2015
Accepted: 20 January 2015
Published: 19 February 2015
The original article was published in BMC Infectious Diseases 2014 14:17
Following publication of this article (Daw and El-Bouzedi, BMC Infectious Diseases 2014, 14:17)  it has been brought to the Editors’ attention that much of this data appears to have been previously published in the following article . In addition concerns about the authors’ right to use this data have been raised. Despite extensive efforts to obtain an independent investigation, we have been unable to secure advice on the matter. Given the uncertainty, the Editors advise the readers to interpret the data with due caution. We apologize to all affected parties.
- Daw MA, El-Bouzedi A. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis. 2014;14:17.View ArticlePubMedPubMed CentralGoogle Scholar
- Elzouki NA, Smeo MN, Sammud M, Elahmer O, Daw M, Furarah A, et al. Prevalence of hepatitis B and C virus infections and their related risk factors in Libya: a national seroepidemiological survey. East Mediterr Health J. 2013;19(7):589–99.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.